Convergence of Cell Pharmacology and Drug Delivery

Ayesha Aijaz, Natalie Vaninov, Ashley Allen, Rita N. Barcia, Biju Parekkadan

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


Cellular therapy is enabling new approaches to tackle significant unmet needs in areas such as regenerative medicine and immunotherapy. The pharmacology of cell therapeutics becomes of critical importance to assure that these new drugs work reproducibly and effectively. Cell pharmacology can benefit from adapting principles of classical molecular drug pharmacokinetics (PK) and pharmacodynamics (PD) to quantitatively understand rate-limiting constraints of cell fate after administration. Future innovations focused on improvements in drug delivery using a PK/PD perspective can aid in designing a cell therapeutic product to overcome any pharmacological barriers for a given disease application. Herein, we present a perspective on the development of an ex vivo mesenchymal stromal therapeutic using a PK/PD framework and also present examples of general cell engineering techniques that implicitly influence the PK/PD curve by genetically modifying cells to regulate their in vivo duration, biodistribution, and activity. Stem Cells Translational Medicine 2019;8:874&879.

Original languageEnglish
Pages (from-to)874-879
Number of pages6
JournalStem cells translational medicine
Issue number9
StatePublished - 2019
Externally publishedYes


Dive into the research topics of 'Convergence of Cell Pharmacology and Drug Delivery'. Together they form a unique fingerprint.

Cite this